Uchida M, Nakamura T, Watanabe H, Kato K, Miyamoto T, Akashi K, Masuda S
Pharmazie. 2019 Sep 1;74(9):566-569. doi: 10.1691/ph.2019.9467.
Patients receiving cancer chemotherapy may experience a number of potentially severe adverse drug reactions. It is crucial for all members of the health care team to monitor the effect of medicines on the patient to ensure the safety and efficacy of the chemotherapy. The present study prepared medication instruction sheets (MISs) on hematological malignancy and conducted a questionnaire survey to verify their usefulness among physicians, dentists, and nurses. MISs were prepared for 103 chemotherapy and 44 pretreatment regimens for hematopoietic stem cell transplantation in the Department of Hematology at Kyushu University Hospital. Eight questions were prepared to investigate whether MISs could help physicians, dentists, and nurses manage cancer chemotherapy more safely, effectively, and efficiently, as well as in the sharing of information. A total of 35 medical staff working in inpatient wards, including 8 physicians, 3 dentists, and 24 nurses, participated in the questionnaire survey. All of the staff responded to the questionnaire survey, which showed that the MISs were favorably accepted by the participants. There was no negative opinion on the management of chemotherapy using the MISs. The MIS was a useful tool for sharing information on cancer chemotherapy between patients and medical staff and for enabling efficient management, thereby improving the safety and efficacy of treatment.
接受癌症化疗的患者可能会经历一些潜在的严重药物不良反应。医疗团队的所有成员监测药物对患者的影响以确保化疗的安全性和有效性至关重要。本研究编制了关于血液系统恶性肿瘤的用药指导单，并进行了问卷调查以验证其在医生、牙医和护士中的有用性。九州大学医院血液科针对103种化疗方案和44种造血干细胞移植预处理方案编制了用药指导单。准备了八个问题来调查用药指导单是否能帮助医生、牙医和护士更安全、有效和高效地管理癌症化疗以及信息共享。共有35名在住院病房工作的医务人员参与了问卷调查，其中包括8名医生、3名牙医和24名护士。所有工作人员都对问卷调查做出了回应，结果显示参与者对用药指导单的接受度很高。对于使用用药指导单进行化疗管理没有负面意见。用药指导单是患者和医务人员之间共享癌症化疗信息以及实现高效管理的有用工具，从而提高了治疗的安全性和有效性。
